About Jonathan Gillis
Jonathan Gillis is CAO and Interim CFO at MapLight Therapeutics.
Jonathan Gillis reports to the SEC as an officer of 2 public companies, including Tempest Therapeutics (TPST).
Jonathan Gillis first appears on SEC filings in 2017.
Experience
This experience comes from SEC filings. The years are when the filings name Jonathan Gillis in the role, so the role may have started earlier or lasted longer.
TI
Tempest Therapeutics, Inc.
Senior Vice President, Finance
2017 – 2018 · Public company (TPST)
Key Colleagues at Startups
The people Jonathan Gillis works with at each company, as listed on that company's latest Form D.
MapLight Therapeutics, Inc. · Form D, Jul 28, 2025
KH
Kristopher Hanson
Executive officer
TG
Timothy Garnett
Director
GP
George Pavlov
Director
PB
Peter Bisgaard
Director
EF
Erin Foff
Executive officer
AK
Anatol Kreitzer
Executive officer
JT
Jim Trenkle
Director
JL
James Lillie
Executive officer
MW
Maria Walker
Director
CK
Christopher Kroeger
Chief Executive Officer and director
VS
Vishwas Setia
Executive officer
NL
Nanna Luneborg
Director